CROSSJECT (XPAR:ALCJ) YoY EBITDA Growth : 47.11% (As of Jun. 2023)

View and export this data going back to 2014. Start your Free Trial

What is CROSSJECT YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. CROSSJECT's YoY EBITDA Growth for the quarter that ended in Jun. 2023 was 47.11%.

CROSSJECT's EBITDA per Share for the six months ended in Jun. 2023 was €-0.06.

CROSSJECT YoY EBITDA Growth Historical Data

The historical data trend for CROSSJECT's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CROSSJECT YoY EBITDA Growth Chart

CROSSJECT Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

YoY EBITDA Growth

Get a 7-Day Free Trial

32.59

54.69

-19.17

14.78

-3.06

CROSSJECT Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
YoY EBITDA Growth	Get a 7-Day Free Trial															74.66	16.04	-227.03	7.87	47.11

CROSSJECT YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

CROSSJECT's YoY EBITDA Growth for the fiscal year that ended in Dec. 2022 is calculated as:

	YoY EBITDA Growth (A: Dec. 2022 )
=	(EBITDA per Share (A: Dec. 2022 )	-	EBITDA per Share (A: Dec. 2021 ))	/	\| EBITDA per Share (A: Dec. 2021 ) \|
=	(-0.202	-	-0.196)	/	\| -0.196 \|
=	-3.06 %

CROSSJECT's YoY EBITDA Growth for the quarter that ended in Jun. 2023 is calculated as:

	YoY EBITDA Growth (Q: Jun. 2023 )
=	(EBITDA per Share (Q: Jun. 2023 )	-	EBITDA per Share (Q: Jun. 2022 ))	/	\| EBITDA per Share (Q: Jun. 2022 )) \|
=	(-0.064	-	-0.121)	/	\| -0.121 \|
=	47.11 %

CROSSJECT YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of CROSSJECT's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

CROSSJECT (XPAR:ALCJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CROSSJECT (XPAR:ALCJ) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

74C:Germany

Address

60L avenue du 14 Juillet, Chenôve, FRA, 21300

Website

http://www.crossject.com

CROSSJECT manufactures and markets needle-free drug self-injection system.

CROSSJECT (XPAR:ALCJ) Headlines

No Headlines